MAPT and Alzheimer disease: Interestingly, the rs62625753 (c.268G>A; Gly90Ser) mutation in exon 3 was recently shown to produce abnormal aggregation of tau proteins and contribute to cognitive degeneration, suggesting a functional impact for AD [115].